Cardiology and Cardiovascular Medicine papers
Pofolia’s corpus holds 102 papers from Cardiology and Cardiovascular Medicine (2012–2026), each with a short summary. Below, the 20 most-cited, then the most recently added.
At a glance
- Most cited: 2013 ESH/ESC Guidelines for the management of arterial hypertension (2013, 13,682 citations).
- The 20 papers listed have 189,939 citations between them.
- 17 of the 19 with a known journal quartile appeared in a Q1 journal.
- 13 have a free full text (open access).
- Most frequent journals: European Heart Journal, Circulation, Cerebrovascular Diseases.
- Published between 2012 and 2021.
Most cited
Ranked by citation count. Because citations accumulate over time, this list naturally leans towards work published a few years ago; for where the field is now, see “recently added”. How to read the signals
2013 ESH/ESC Guidelines for the management of arterial hypertension
European Heart Journal · 2013 · Q1 · SJR 5.00 · FWCI 882.48 · 13,682 citations · Open access
The 2013 ESH/ESC Guidelines offer recommendations for managing arterial hypertension, emphasizing their role as a guide for clinical judgment rather than a rigid rulebook.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
European Heart Journal · 2021 · Q1 · SJR 5.00 · FWCI 1282.53 · 13,147 citations · Open access
These guidelines provide the European Society of Cardiology's (ESC) recommendations for diagnosing and treating heart failure, based on current scientific evidence.
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
The Nephron journals/Nephron journals · 2016 · Q2 · FWCI 726.68 · 11,736 citations
The benefit of continuing ACE inhibitors (ACEi) or angiotensin II receptor blockers (ARBs) in advanced chronic kidney disease (CKD) with an estimated GFR (eGFR) below 30 ml/min/1.73 m2 remains uncertain, with no clear evidence of cardiovascular risk reduction in this population.
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
Cerebrovascular Diseases · 2014 · Q2 · FWCI 186.84 · 11,558 citations · Open access
Short-term (≤3 months) dual antiplatelet therapy with aspirin and clopidogrel significantly reduces stroke recurrence and major vascular events by 31% and 30% respectively, without increasing bleeding risk, compared to single antiplatelet therapy.
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
European Heart Journal · 2016 · Q1 · SJR 5.00 · FWCI 757.84 · 11,536 citations · Open access
The 2016 European Society of Cardiology (ESC) guidelines provide updated recommendations for diagnosing and treating acute and chronic heart failure.
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Journal of the American College of Cardiology · 2020 · Q1 · SJR 8.00 · FWCI 644.27 · 11,235 citations
Cardiovascular diseases (CVDs) are the leading global cause of death and disability, with prevalent cases nearly doubling from 271 million in 1990 to 523 million in 2019.
2018 ESC/ESH Guidelines for the management of arterial hypertension
European Heart Journal · 2018 · Q1 · SJR 5.00 · FWCI 708.55 · 10,478 citations · Open access
These guidelines provide updated evidence-based recommendations for health professionals to manage arterial hypertension in individual patients.
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
European Heart Journal · 2020 · Q1 · SJR 5.00 · FWCI 837.05 · 9,979 citations
These guidelines provide updated recommendations for the diagnosis and management of atrial fibrillation, developed in collaboration with EACTS.
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
European Heart Journal · 2017 · Q1 · SJR 5.00 · FWCI 540.33 · 9,797 citations · Open access
These updated European Society of Cardiology (ESC) guidelines provide a comprehensive summary and evaluation of current evidence to assist health professionals in managing ST-segment elevation acute myocardial infarction (STEMI).
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Circulation · 2020 · Q1 · SJR 8.00 · FWCI 957.60 · 9,395 citations · Open access
This annual report provides the latest statistics on heart disease, stroke, and related risk factors in the United States, consolidating data on core health behaviors, clinical conditions, and outcomes.
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
European Heart Journal · 2012 · Q1 · SJR 5.00 · FWCI 427.90 · 8,522 citations · Open access
These 2012 guidelines consolidate evidence for cardiovascular disease (CVD) prevention, updating recommendations for risk assessment, lifestyle interventions, and pharmacological treatments.
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
European Heart Journal - Cardiovascular Imaging · 2015 · Q1 · SJR 2.00 · FWCI 309.04 · 8,358 citations · Open access
Updated guidelines for cardiac chamber quantification by echocardiography in adults have been released, incorporating recent technological advancements and larger datasets.
Heart disease and stroke statistics--2015 update: a report from the American Heart Association.
PubMed · 2015 · FWCI 969.90 · 8,341 citations
The 2015 update from the American Heart Association presents comprehensive statistics on heart disease and stroke, highlighting their significant impact on public health and healthcare systems.
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
European Heart Journal · 2015 · Q1 · SJR 5.00 · FWCI 630.07 · 8,324 citations · Open access
These guidelines provide updated recommendations for managing acute coronary syndromes (ACS) in patients without persistent ST-segment elevation (NSTE-ACS). They emphasize early risk stratification and tailored treatment strategies.
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
JAMA · 2013 · Q1 · SJR 5.00 · FWCI 494.08 · 8,015 citations
New guidelines recommend treating adults 60+ to a BP goal of <150/90 mmHg, and those 30-59 to a diastolic goal of <90 mmHg, based on strong evidence. For younger adults or those under 30, a goal of <140/90 mmHg is recommended based on expert opinion due to insufficient evidence.
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Hypertension · 2017 · Q1 · SJR 3.00 · FWCI 483.22 · 7,395 citations
This report presents the 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults, developed through collaboration with multiple professional organizations.
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
Circulation · 2018 · Q1 · SJR 8.00 · FWCI 715.67 · 7,224 citations
This report compiles the latest statistics on heart disease, stroke, and related cardiovascular risk factors from leading health organizations.
2018 ESC/EACTS Guidelines on myocardial revascularization
European Heart Journal · 2018 · Q1 · SJR 5.00 · FWCI 499.25 · 7,156 citations · Open access
These guidelines provide a comprehensive summary and evaluation of current evidence to assist physicians in selecting optimal management strategies for myocardial revascularization.
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
Circulation · 2014 · Q1 · SJR 8.00 · FWCI 567.60 · 7,151 citations · Open access
This document presents the official 2014 clinical practice guidelines for managing patients with atrial fibrillation, developed by the American Heart Association, American College of Cardiology, and Heart Rhythm Society.
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
European Heart Journal · 2012 · Q1 · SJR 5.00 · FWCI 538.51 · 6,910 citations · Open access
The 2012 ESC Guidelines provide a comprehensive framework for diagnosing and treating acute and chronic heart failure, emphasizing early identification and risk stratification.
Recently added
Sex differences in the associations of body composition and PPARGC1A genetic variants with elevated pulse pressure
Scientific Reports · 2026 · Q1
Fat-free mass index (FFMI) is linked to elevated pulse pressure (PP) in both sexes, but adiposity indices like visceral fat area are significant only in females, according to a study of 5,829 adults. Three PPARGC1A gene variants also independently contribute to elevated PP.
Evaluating sex as a modifier of cardiomyocyte relaxation in heart failure with preserved ejection fraction: calcium handling, titin, and bioenergetics
Biology of Sex Differences · 2026 · Q1 · SJR 1.00
Current evidence does not support sex as a sole determinant for classifying HFpEF subtypes or guiding treatment, as reported sex differences in cardiomyocyte relaxation mechanisms (calcium handling, titin, bioenergetics) are inconsistent and model-dependent.
Myocardial late gadolinium enhancement is strongly associated with ventricular arrhythmias in mitral valve prolapse
The International Journal of Cardiovascular Imaging · 2026 · Q2
Myocardial late gadolinium enhancement (M-LGE) of 5% or more of left ventricular (LV) mass on cardiac MRI (CMR) is strongly associated with a combined endpoint of ventricular arrhythmias in mitral valve prolapse (MVP) patients.
Association between pericoronary CT fat attenuation index and coronary artery spasm
Medicine · 2026 · Q2
Pericoronary fat attenuation index (FAI) is significantly lower in patients with coronary artery spasm (CAS) compared to controls, and elevated FAI is an independent risk factor for CAS.
Heart rate variability and physician performance during airway management simulations: an exploratory pilot study
European Archives of Oto-Rhino-Laryngology · 2026 · Q1 · Open access
Physician performance in airway management simulations was associated with heart rate variability (HRV), with lower HRV correlating with higher performance when measured immediately before the task, and higher HRV correlating with higher performance when measured days prior.
Exercise-based cardiac rehabilitation and health-related quality of life in coronary artery disease: a systematic review and meta-analysis by exercise modality and disease status
BMC Cardiovascular Disorders · 2026 · Q2
Exercise-based cardiac rehabilitation improves health-related quality of life (HR-QoL) in coronary artery disease (CAD) patients, with a moderate effect size (Hedges’ g = 0.89). Combined aerobic and resistance training, and rehabilitation in the post-ACS stable phase, showed larger point estimates, though evidence certainty is low.
Assessment of Lifestyle Self-Efficacy and Knowledge of Myocardial Infarction Symptoms Among Hypertensive Adults in Saudi Arabia: A Cross-Sectional Study
Healthcare · 2026 · Q1
Hypertensive adults in Saudi Arabia report moderate confidence (average score 50.33/100) in lifestyle self-efficacy but demonstrate limited knowledge of myocardial infarction (MI) symptoms, scoring only 3.47 out of 12.
Machine learning and deep learning–based prediction of hypertension and analysis of its major risk factors in Bangladesh
PLoS ONE · 2026 · Q1
Random Forest (RF) model achieved the highest recall (68.7%) and F1-score (0.460) for predicting hypertension in Bangladesh, outperforming other ML/DL models in identifying affected individuals, despite Weighted Logistic Regression showing higher overall accuracy (81.7%).
Journals in this field
The journals that publish most of this field’s papers. Quartile (Q1–Q4), SJR and h-index are from SCImago Journal Rank; “in this field” is how many of the journal’s pooled papers belong here. What is a Q1 journal? · What is the h-index?
| Journal | Quartile | SJR | h-index | In this field | Summaries |
|---|---|---|---|---|---|
| European Heart Journal | Q1 | 5.00 | 385 | 28 | 50 |
| Circulation | Q1 | 8.00 | 712 | 11 | 46 |
| New England Journal of Medicine | Q1 | 18.00 | 1275 | 10 | 376 |
| Journal of the American College of Cardiology | Q1 | 8.00 | 531 | 4 | 5 |
| npj Digital Medicine | Q1 | 4.00 | 130 | 3 | 11 |
| Journal of Hypertension | Q1 | 1.00 | 201 | 3 | 3 |
| BMC Cardiovascular Disorders | Q2 | — | 81 | 2 | 4 |
| JAMA | Q1 | 5.00 | 818 | 1 | 114 |
Every journal in Cardiology and Cardiovascular Medicine (Q1–Q4) →
Add this field to your daily feed
Pick your interests and new work in your area arrives every day, summarised. Full summaries live in the app.
Open the app